FIELD: medicine.
SUBSTANCE: present invention relates to sustained release naltrexone delivery systems in the form of microspheres for treating diseases relieved by naltrexone.
EFFECT: injection delivery system in the form of microspheres includes naltrexone encapsulated in biodegradable microspheres administered in a pharmaceutically acceptable carrier.
11 cl, 10 tbl, 8 dwg, 12 ex
Title | Year | Author | Number |
---|---|---|---|
PREPARATION OF POLYLACTIDE-POLYGLYCOLIDE MICROPARTICLES CHARACTERISED BY SIGMOIDAL RELEASE PROFILE | 2014 |
|
RU2658004C2 |
COMPOSITIONS WITH PROLONGED ACTION BASED ON NALTREXONE AND METHODS OF THEIR APPLICATION | 2005 |
|
RU2370257C2 |
CORTICOSTEROIDS FOR JOINT PAIN TREATMENT | 2011 |
|
RU2642279C2 |
PROLONGED RELEASE FORMULATION CONTAINING OCTREOTIDE AND THREE LINEAR POLYMERS OF POLY(LACTIDE-CO-GLYCOLIC ACID) | 2009 |
|
RU2541104C2 |
MICROPARTICLES AND METHOD OF THEIR PREPARING | 1997 |
|
RU2201214C2 |
SUNITINIB-BASED COMPOSITIONS AND METHODS FOR USING THEM FOR TREATING EYE DISEASES | 2015 |
|
RU2729731C2 |
COMPOSITIONS OF PROLONGEDACTION WITH CONTROLLED RELEASE | 2003 |
|
RU2355385C2 |
DOSED FORMS OF ANESTHETICS FOR ANESTHESIA WITH LONG LIBERATION | 2003 |
|
RU2332985C2 |
COMPOSITION WITH DELAYED RELEASE, INCLUDING OCTREOTIDE AND TWO OR MORE POLYLACTIDE AND GLYCOLIDE COPOLYMERS | 2006 |
|
RU2464972C2 |
DELIVERED PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS | 2005 |
|
RU2390355C2 |
Authors
Dates
2024-04-09—Published
2019-10-15—Filed